401 related articles for article (PubMed ID: 147147)
21. Macrophage inhibitor factor (MIF) in cutaneous lymphoproliferative diseases.
Umbert P; Belcher RW; Winkelmann RK
Br J Dermatol; 1976 Nov; 95(5):475-80. PubMed ID: 136265
[TBL] [Abstract][Full Text] [Related]
22. The pathogenesis of mycosis fungoides.
Girardi M; Heald PW; Wilson LD
N Engl J Med; 2004 May; 350(19):1978-88. PubMed ID: 15128898
[No Abstract] [Full Text] [Related]
23. Prospectives in mycosis fungoides in relation to other lymphomas.
Jones EW
Trans St Johns Hosp Dermatol Soc; 1975; 61(1-2):16-30. PubMed ID: 128163
[No Abstract] [Full Text] [Related]
24. [A case of cutaneous T cell lymphoma (mycosis fungoides) associated with multiple hematological malignancies in the patient's sibship].
Nara N; Miyamoto T; Kurisu A; Tsunemoto H; Ohtsu Y; Tanabe E
Rinsho Ketsueki; 1980 Jul; 21(7):1007-12. PubMed ID: 6968363
[No Abstract] [Full Text] [Related]
25. Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome.
Burg G; Rodt H; Grosse-Wilde H; Braun-Falco O
J Invest Dermatol; 1978 May; 70(5):257-9. PubMed ID: 147911
[TBL] [Abstract][Full Text] [Related]
26. Is there a role for epigenetic factors in the pathogenesis of epidermotropic cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome)?
Bachelez H
Hematol J; 2001; 2(4):286-9. PubMed ID: 11920262
[No Abstract] [Full Text] [Related]
27. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
[TBL] [Abstract][Full Text] [Related]
28. [Cutaneous T-cell lymphomas].
Burg G; Braun-Falco O; Schmoeckel C
Fortschr Med; 1978 Feb; 96(5):199-205. PubMed ID: 146018
[No Abstract] [Full Text] [Related]
29. [Sézary syndrome. Clinical, immunological and proliferative kinetics].
Marosi L; Hofer F; Schwarzmeier J; Konrad K; Knapp W; Radaskiewicz T
Acta Med Austriaca; 1979; 6(5):237-40. PubMed ID: 318012
[TBL] [Abstract][Full Text] [Related]
30. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
[TBL] [Abstract][Full Text] [Related]
31. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
Thivolet J; Schmitt D; Souteyrand P; Brochier J
Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
33. Locomotion of T cells from patients with cutaneous T-cell lymphoma (Sézary syndrome and mycosis fungoides).
Gupta S; Safai B; Edelson R; Parrott D; Good R
Cell Immunol; 1980 Mar; 50(1):195-201. PubMed ID: 6967357
[No Abstract] [Full Text] [Related]
34. Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation.
Wood GS; Strickler JG; Deneau DG; Egbert B; Warnke RA
J Am Acad Dermatol; 1986 Sep; 15(3):444-58. PubMed ID: 3489740
[TBL] [Abstract][Full Text] [Related]
35. [IgE and cellular immunity in cutaneous lymphomas (author's transl)].
Guilhou JJ; Clot J; Robinet-Lévy M; Meynadier J
Ann Dermatol Venereol; 1977; 104(8-9):533-7. PubMed ID: 303883
[TBL] [Abstract][Full Text] [Related]
36. Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome.
Shono Y; Suga H; Kamijo H; Fujii H; Oka T; Miyagaki T; Shishido-Takahashi N; Sugaya M; Sato S
Acta Derm Venereol; 2019 Jul; 99(9):809-812. PubMed ID: 31045236
[TBL] [Abstract][Full Text] [Related]
37. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
[TBL] [Abstract][Full Text] [Related]
38. Variants of mycosis fungoides and related cutaneous T-cell lymphomas.
LeBoit PE
Semin Diagn Pathol; 1991 May; 8(2):73-81. PubMed ID: 1871452
[No Abstract] [Full Text] [Related]
39. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
40. A modified staging classification for cutaneous T-cell lymphoma.
Kashani-Sabet M; McMillan A; Zackheim HS
J Am Acad Dermatol; 2001 Nov; 45(5):700-6. PubMed ID: 11606919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
